Danaher Corporation
NYSE:DHRMedical - Diagnostics & Research
-$0.38 today
- Market cap
- $160.69B
- Beta
- 0.83
- P/E (TTM)
- 34.0
- EPS (TTM)
- $5.21
- Dividend yield
- 0.77%
Volume 2.92M
Average 4.52M
DHR Total Current Liabilities
All obligations due within one year.
Danaher CorporationNYSE: DHR
Total Current Liabilities · Q3 FY2026 · quarter ended Sep 2026
Total current liabilities rises 43.1% from a year ago
Total current liabilities stood at $9.05B at the end of Q3 FY2026, up 43.1% from a year earlier and up 11.7% from the prior quarter. Over 3 fiscal years it compounded at -6.7% a year.
Context
- Total current liabilities amounted to 9.7% of total assets at the end of Q3 FY2026, up 1.8 pp from a year earlier.
- Total current liabilities increased in 1 of the last 3 fiscal years.
What to watch
Whether total current liabilities keeps rising in the next quarterly balance sheet after a +43.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 6.81B USD
- Year-over-year change
- +0.1%
- 4-year CAGR
- -4.4%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.81B | +0.1% |
| FY2024 | 2024-12-31 | 6.8B | -17.8% |
| FY2023 | 2023-12-31 | 8.27B | -1.4% |
| FY2022 | 2022-12-31 | 8.39B | +3.1% |
| FY2021 | 2021-12-31 | 8.14B | — |
Total Current Liabilities vs competitors
How DHR compares with its peers on the latest reported figures
- DHR's Sep 2026 total current liabilities of $9.05B is the 2nd highest of the 9 companies compared; the peer median is $1.43B.
- Its year-over-year change of +43.1% is the 3rd highest of 9, against a peer median of +8.2%.
- Total current liabilities amounts to 9.7% of total assets for DHR, versus a peer median of 14.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $14.17B | -4.8% | -3.7% | 12.4% | |
| Sep 2026 | $9.05B | +43.1% | -6.7% | 9.7% | |
| Jul 2026 | $2.4B | +136.1% | +16.4% | 9.7% | |
| Jul 2026 | $2.29B | +21.0% | +8.0% | 16.4% | |
| Jun 2026 | $1.58B | +8.0% | -17.0% | 23.7% | |
| Jul 2026 | $1.28B | +90.0% | -4.8% | 10.6% | |
| Jun 2026 | $1.2B | -10.6% | +11.8% | 19.9% | |
| Jun 2026 | $1.2B | +8.5% | +1.4% | 32.7% | |
| Jun 2026 | $581.45M | -48.5% | -19.3% | 9.9% | |
| Peer median (excluding DHR) | $1.43B | +8.2% | -1.1% | 14.4% | |
Competitors are the stored peer set for DHR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2.59B | 6B | 5.86B | 2.08B | 4.62B |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 5.44B | 5.06B | 4.64B | 4.39B | 3.91B |
| Inventory | 2.77B | 2.77B | 2.59B | 2.33B | 2.49B |
| Other Current Assets | 82M | 1.36B | 71M | 79M | 1.74B |
| Total Current Assets | 11.65B | 15.88B | 13.94B | 9.5B | 12.76B |
| Property, Plant & Equipment (Net) | 4.83B | 4.59B | 5.61B | 6.07B | 6.75B |
| Goodwill | 41.18B | 37.28B | 41.61B | 40.5B | 43.15B |
| Intangible Assets | 22.84B | 19.82B | 20.75B | 18.57B | 17.82B |
| Long-term Investments | 1.32B | 2.16B | 1.7B | 1.82B | 1.55B |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 1.36B | 4.61B | 896M | 1.09B | 1.45B |
| Total Non-current Assets | 71.54B | 68.47B | 70.55B | 68.05B | 70.71B |
| Total Assets | 83.18B | 84.35B | 84.49B | 77.54B | 83.46B |
| Account Payables | 2.57B | 1.86B | 1.77B | 1.75B | 1.84B |
| Short-term Debt | 215M | 758M | 1.88B | 505M | 2M |
| Tax Payables | 707M | 691M | 582M | 0 | 0 |
| Deferred Revenue | 1.61B | 1.46B | 1.47B | 1.3B | 0 |
| Other Current Liabilities | 1.59B | 2.48B | 1.4B | 1.34B | 4.96B |
| Total Current Liabilities | 8.14B | 8.39B | 8.27B | 6.8B | 6.81B |
| Long-term Debt | 22.17B | 19.09B | 16.71B | 15.5B | 18.42B |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 213M | 221M | 249M | 232M | 0 |
| Other Non-current Liabilities | 6.6B | 5.79B | 4.81B | 4.49B | 5.71B |
| Total Non-current Liabilities | 29.87B | 25.87B | 22.72B | 21.19B | 24.12B |
| Total Liabilities | 38.01B | 34.26B | 31B | 27.99B | 30.93B |
| Common Stock | 9M | 9M | 9M | 9M | 9M |
| Retained Earnings | 32.83B | 39.21B | 41.07B | 44.19B | 46.89B |
| Accumulated OCI | (1.03B) | (2.87B) | (1.75B) | (3.22B) | (207M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 10M | 8M | 4M | 7M | 7M |
| Total Equity | 45.18B | 50.09B | 53.49B | 49.55B | 52.54B |
| Total Debt | 23.27B | 20.62B | 19.54B | 17.15B | 18.42B |
| Net Debt | 20.69B | 14.62B | 13.67B | 15.07B | 13.8B |
Danaher Corporation
NYSE:DHR
Intrinsic Alpha fair value
Locked
Current Price
$228.41
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.